The Global Organ Transplant Rejection Medications Market was valued at US$ 4.7 Bn in 2020 and is projected to expand at a CAGR of 3% from 2022 to 2028. The organ transplant rejection drug market is mainly dominated by kidney transplants as the number of kidney transplants continues to outperform other types of organ transplants such as bone marrow transplants, […]
